The morphological effects of the anti-tumor agents flavone acetic acid and 5,6-dimethyl xanthenone acetic acid on the colon 38 mouse tumor

Pathology

Volumn 26, Issue 2, 1994, Pages 161-169

  Zwi, L Jonathan ^a   Baguley, Bruce C ^a   Gavin, John B ^a   Wilson, William R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Adenosine triphosphate; Blood vessels; Flavone acetic acid; Flavones; Necrosis; Neoplasms; Xanthenone acetic acid

Indexed keywords

5,6 DIMETHYLXANTHENONEACETIC ACID; 5,6-DIMETHYLXANTHENONEACETIC ACID; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FLAVONE DERIVATIVE; MITOFLAXONE; XANTHENE DERIVATIVE;

ADENOCARCINOMA; ANIMAL; APOPTOSIS; ARTICLE; COLON TUMOR; COMPARATIVE STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; METABOLISM; MOUSE; MOUSE STRAIN; NECROSIS; PATHOLOGY; VASCULARIZATION;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; ANIMAL; APOPTOSIS; COLONIC NEOPLASMS; COMPARATIVE STUDY; FLAVONES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICROSCOPY, ELECTRON; NECROSIS; PHOSPHOCREATINE; SUPPORT, NON-U.S. GOV'T; XANTHENES;

EID: 0028412770     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313029400169411     Document Type: Article

References (40)

1. Bibby MC, Double JA, Loadman PM. Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512). Br J Cancer 1988; 58: 341-4.
2. Finlay GJ, Smith GP, Fray LM et al. Effect of flavone acetic acid (NSC 24712) on Lewis lung carcinoma; evidence for an indirect effect. J Natl Cancer Inst 1988; 80: 241-5.
3. Ching L-M, Baguley BC. Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512). Eur J Cancer Clin Oncol 1988; 24: 1521-5.
4. Zwi LJ, Baguley BC, Gavin JB et al. The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids. Oncol Res 1992; 4: 333-9.
5. Zwi LJ, Baguley BC, Gavin JB et al. Blood flow failure as a major determinant in the antitumor activity of flavone acetic acid. J Natl Cancer Inst 1989; 81: 1005-13.
6. Mahadevan V, Malik STA, Meager A et al. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res 1990; 50: 5537-42.
7. Peters CE, Trotter MJ, Chaplin DJ. Early spatial and temporal changes in tumour perfusion after administration of flavone acetic acid. Int J Radiat Biol 1991; 60: 341-8.
8. Baguley BC, Calveley SB, Crowe KK et al. Comparison of the effects of flavone acetic acid, fostriecin and homoharringtonine and tumour necrosis factor α on Colon 38 tumors in mice. Eur J Cancer Clin Oncol 1989; 25: 263-9
9. Watanabe N, Niitsu Y, Umeno H et al. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res 1988; 48: 2179-83.
10. Shimomura K, Manda T, Mukumoto S et al. Recombinant human tumor necrosis factor-α thrombus formation is a cause of antitumor activity. Int J Cancer 1988; 41: 243-7.;
11. Van de Wiel PA, Bloksma N, Kuper CF et al. Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A Sarcoma, and relation to curative activity. J Pathol 1989; 157: 65-73.
12. Bissery M-C, Valeriote FA, Chabot GG et al. Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. Cancer Res 1988; 48: 1279-85.
13. Bibby MC, Double JA, Loadman PM et al. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. J Natl Cancer Inst 1989; 81: 216-20.
14. Sun J, Brown JM. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. Cancer Res 1989; 49: 5664-70.
15. Zwi LJ, Baguley BC, Gavin JB, Wilson WR. The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour vessels. Br J Cancer 1990; 62: 231-7.
16. Kerr DJ, Maughan T, Newlands E et al. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. Br J Cancer 1989; 60: 104-6.
17. Havlin KA, Kuhn JG, Craig JB et al. Phase I clinical and pharmacokinetic trial of flavone acetic acid. J Natl Cancer Inst 1991; 83: 124-8.
18. Rewcastle GW, Atwell GJ, Baguley BC et al. Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the Colon 38 tumor in vivo. J Med Chem 1989; 32: 793-9.
19. Rewcastle GW, Atwell GJ, Zhuang L et al. Potential antitumor agents. 61. Structure-activity relationships for in vivo Colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids. J Med Chem 1990; 34: 217-22.
20. Corbett TH, Griswold DP, Roberts BJ et al. A mouse colon-tumor model for experimental therapy. Cancer Chemother Rep 1975; 5: 169-86.
21. Ching L-M, McKeage MJ, Joseph WR et al. Haematologieal effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-methyl-xanthenone-4-acetic acid and flavone acetic acid. Cancer Chemother Pharmacol 1991; 28: 414-9.
22. Holliss DG, Humphrey SM, Morrison MA et al. Reverse phase HPLC for rapid, comprehensive measurement of nucleotides, nucleosides and bases of the myocardial adenine pool. Analyt Lett 1984; 17: 2047-65.
23. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955; 9: 539-49.
24. Searle J, Lawson TA, Abbott PJ et al. An electromicroscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol 1975; 116: 129-38.
25. Kerr JF, Bishop CJ, Searle J. Apoptosis. In: Anthony PP, MacSween RNM, eds. Recent advances in histopathology 12. Chapter 2. London, UK: Churchill Livingstone, 1984.
26. Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 1993; 67: 205-8.
27. Anilkumar TV, Sarraf CE, Hunt T et al. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br J Cancer 1992; 65: 552-8.
28. Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990; 2: 275-80.
29. Ijiri K, Potten CS. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents. Br J Cancer 1987; 55: 113-23.
30. Ching L-M, Finlay GJ, Joseph WR et al. In vitro methods of screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acid. Eur J Cancer 1991; 22: 1684-9. ‘
31. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 1988; 141: 2629-34.
32. Jennings RB, Reimer KA, Hill ML et al. Total ischemia in dog hearts, in vitro. 1. Comparison of high energy phosphate production, utilization, and depletion, and of adenine nucleotide catabolism in total ischemia in vitro vs severe ischemia in vivo. Circ Res 1981; 49: 892-900.
33. Evelhoch JL, Bissery M-C, Chabot GG et al. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Res 1988; 48: 4749-55.
34. Zwi LJ, Baguley BC, Gavin JB et al. Necrosis in non-tumour tissues caused by flavone acetic acid and 5,6-dimethyl xanthenone acetic acid. Br J Cancer 1990; 62: 932-4.
35. Rathjen DA, Furphy LJ, Aston R. Selective enhancement of the tumour necrotic activity of TNFα With monoclonal antibody;Br J Cancer 1992; 65: 852-6.
36. Wiig H, Tveit E, Hultborn R et al. Interstitial fluid pressure in DMBA-induced rat mammary tumours. Scand J Clin Lab Invest 1982; 42: 159-64.
37. Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 1990; 50: 4478-84.
38. Asher A, Mule JJ, Reichert CM et al. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumor in vivo. J Immunol 1987; 138: 963-74.
39. North RJ, Havell EA. The antitumor function of tumor necrosis factor (TNF). II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma. J Exp Med 1988; 167: 1086-99.
40. Nishimura Y, Hiraoka M, Jo S et al. Microangiographic and histological analysis of the effects of hyperthermia on murine tumor vasculature. Int J Radiation Oncolocy Biol Phys 1988; 15: 411-20.